| UniProt ID | FL2D_HUMAN | |
|---|---|---|
| UniProt AC | Q15007 | |
| Protein Name | Pre-mRNA-splicing regulator WTAP {ECO:0000305} | |
| Gene Name | WTAP {ECO:0000303|PubMed:11001926, ECO:0000312|HGNC:HGNC:16846} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 396 | |
| Subcellular Localization | Nucleus speckle . Nucleus, nucleoplasm . Cytoplasm . Mainly nuclear with some fraction located in the cytoplasm. ZC3H13 is required to anchor component of the MACOM subcomplex, such as VIRMA, in the nucleus. | |
| Protein Description | Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing. [PubMed: 29507755 Required for accumulation of METTL3 and METTL14 to nuclear speckle] | |
| Protein Sequence | MTNEEPLPKKVRLSETDFKVMARDELILRWKQYEAYVQALEGKYTDLNSNDVTGLRESEEKLKQQQQESARRENILVMRLATKEQEMQECTTQIQYLKQVQQPSVAQLRSTMVDPAINLFFLKMKGELEQTKDKLEQAQNELSAWKFTPDSQTGKKLMAKCRMLIQENQELGRQLSQGRIAQLEAELALQKKYSEELKSSQDELNDFIIQLDEEVEGMQSTILVLQQQLKETRQQLAQYQQQQSQASAPSTSRTTASEPVEQSEATSKDCSRLTNGPSNGSSSRQRTSGSGFHREGNTTEDDFPSSPGNGNKSSNSSEERTGRGGSGYVNQLSAGYESVDSPTGSENSLTHQSNDTDSSHDPQEEKAVSGKGNRTVGSRHVQNGLDSSVNVQGSVL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MTNEEPLP -------CCCCCCCC | 9.07 | 22814378 | |
| 2 | Phosphorylation | ------MTNEEPLPK ------CCCCCCCCC | 51.87 | 20068231 | |
| 2 | Acetylation | ------MTNEEPLPK ------CCCCCCCCC | 51.87 | 20068231 | |
| 9 | Ubiquitination | TNEEPLPKKVRLSET CCCCCCCCCCCCCCC | 72.14 | - | |
| 10 | Ubiquitination | NEEPLPKKVRLSETD CCCCCCCCCCCCCCC | 30.55 | - | |
| 14 | Phosphorylation | LPKKVRLSETDFKVM CCCCCCCCCCCHHHE | 28.08 | 29255136 | |
| 16 | Phosphorylation | KKVRLSETDFKVMAR CCCCCCCCCHHHEEC | 43.28 | 29255136 | |
| 19 (in isoform 1) | Ubiquitination | - | 33.63 | 21890473 | |
| 19 | Ubiquitination | RLSETDFKVMARDEL CCCCCCHHHEECCHH | 33.63 | 21890473 | |
| 19 (in isoform 2) | Ubiquitination | - | 33.63 | 21890473 | |
| 19 | Ubiquitination | RLSETDFKVMARDEL CCCCCCHHHEECCHH | 33.63 | 21890473 | |
| 31 | Ubiquitination | DELILRWKQYEAYVQ CHHHHHHHHHHHHHH | 36.25 | 21906983 | |
| 31 (in isoform 2) | Ubiquitination | - | 36.25 | 21890473 | |
| 31 (in isoform 1) | Ubiquitination | - | 36.25 | 21890473 | |
| 43 (in isoform 2) | Ubiquitination | - | 35.29 | 21890473 | |
| 43 | Ubiquitination | YVQALEGKYTDLNSN HHHHHCCCCCCCCCC | 35.29 | 21906983 | |
| 43 (in isoform 1) | Ubiquitination | - | 35.29 | 21890473 | |
| 44 | Phosphorylation | VQALEGKYTDLNSND HHHHCCCCCCCCCCC | 19.15 | 28152594 | |
| 45 | Phosphorylation | QALEGKYTDLNSNDV HHHCCCCCCCCCCCC | 37.18 | 28152594 | |
| 49 | Phosphorylation | GKYTDLNSNDVTGLR CCCCCCCCCCCCCHH | 41.52 | - | |
| 53 | Phosphorylation | DLNSNDVTGLRESEE CCCCCCCCCHHHHHH | 33.10 | 28985074 | |
| 58 | Phosphorylation | DVTGLRESEEKLKQQ CCCCHHHHHHHHHHH | 44.62 | 25159151 | |
| 61 | Ubiquitination | GLRESEEKLKQQQQE CHHHHHHHHHHHHHH | 57.86 | - | |
| 63 (in isoform 1) | Ubiquitination | - | 58.07 | 21890473 | |
| 63 (in isoform 2) | Ubiquitination | - | 58.07 | 21890473 | |
| 63 | Ubiquitination | RESEEKLKQQQQESA HHHHHHHHHHHHHHH | 58.07 | 21906983 | |
| 69 | Phosphorylation | LKQQQQESARRENIL HHHHHHHHHHHHHHH | 23.80 | 20164059 | |
| 83 | Acetylation | LVMRLATKEQEMQEC HHHHCCCHHHHHHHH | 52.36 | 26051181 | |
| 83 | Ubiquitination | LVMRLATKEQEMQEC HHHHCCCHHHHHHHH | 52.36 | - | |
| 91 | Phosphorylation | EQEMQECTTQIQYLK HHHHHHHHHHHHHHH | 22.45 | 29759185 | |
| 92 | Phosphorylation | QEMQECTTQIQYLKQ HHHHHHHHHHHHHHH | 35.02 | 29759185 | |
| 98 | Ubiquitination | TTQIQYLKQVQQPSV HHHHHHHHHCCCCCH | 43.41 | - | |
| 104 | Phosphorylation | LKQVQQPSVAQLRST HHHCCCCCHHHHHHH | 26.25 | 24043423 | |
| 123 (in isoform 2) | Ubiquitination | - | 33.15 | 21890473 | |
| 123 | Ubiquitination | AINLFFLKMKGELEQ HHHHHHHHHHHHHHH | 33.15 | 21890473 | |
| 123 | Ubiquitination | AINLFFLKMKGELEQ HHHHHHHHHHHHHHH | 33.15 | 21890473 | |
| 123 (in isoform 1) | Ubiquitination | - | 33.15 | 21890473 | |
| 125 | Sumoylation | NLFFLKMKGELEQTK HHHHHHHHHHHHHHH | 47.87 | - | |
| 125 (in isoform 1) | Ubiquitination | - | 47.87 | 21890473 | |
| 125 | Sumoylation | NLFFLKMKGELEQTK HHHHHHHHHHHHHHH | 47.87 | - | |
| 125 | Ubiquitination | NLFFLKMKGELEQTK HHHHHHHHHHHHHHH | 47.87 | 21906983 | |
| 125 (in isoform 2) | Ubiquitination | - | 47.87 | 21890473 | |
| 134 (in isoform 1) | Ubiquitination | - | 56.32 | 21890473 | |
| 134 | Ubiquitination | ELEQTKDKLEQAQNE HHHHHHHHHHHHHHH | 56.32 | 2190698 | |
| 134 (in isoform 2) | Ubiquitination | - | 56.32 | 21890473 | |
| 146 (in isoform 2) | Ubiquitination | - | 38.79 | 21890473 | |
| 146 | Ubiquitination | QNELSAWKFTPDSQT HHHHHHCCCCCCCHH | 38.79 | - | |
| 148 | Phosphorylation | ELSAWKFTPDSQTGK HHHHCCCCCCCHHHH | 23.59 | 21815630 | |
| 155 | Acetylation | TPDSQTGKKLMAKCR CCCCHHHHHHHHHHH | 46.23 | 25953088 | |
| 163 | Sulfoxidation | KLMAKCRMLIQENQE HHHHHHHHHHHHHHH | 5.61 | 21406390 | |
| 191 | Ubiquitination | EAELALQKKYSEELK HHHHHHHHHHHHHHH | 55.30 | - | |
| 239 | Phosphorylation | TRQQLAQYQQQQSQA HHHHHHHHHHHHHHC | 11.59 | 26714015 | |
| 244 | Phosphorylation | AQYQQQQSQASAPST HHHHHHHHHCCCCCC | 24.31 | 17525332 | |
| 250 | Phosphorylation | QSQASAPSTSRTTAS HHHCCCCCCCCCCCC | 38.44 | 28555341 | |
| 254 | Phosphorylation | SAPSTSRTTASEPVE CCCCCCCCCCCCCCC | 26.87 | 23312004 | |
| 255 | Phosphorylation | APSTSRTTASEPVEQ CCCCCCCCCCCCCCC | 27.38 | 23312004 | |
| 257 | Phosphorylation | STSRTTASEPVEQSE CCCCCCCCCCCCCCC | 40.10 | 23312004 | |
| 263 | Phosphorylation | ASEPVEQSEATSKDC CCCCCCCCCCCCCCH | 18.72 | 23312004 | |
| 266 | Phosphorylation | PVEQSEATSKDCSRL CCCCCCCCCCCHHHH | 32.05 | 23312004 | |
| 267 | Phosphorylation | VEQSEATSKDCSRLT CCCCCCCCCCHHHHC | 33.28 | 21712546 | |
| 268 | Acetylation | EQSEATSKDCSRLTN CCCCCCCCCHHHHCC | 59.40 | 25953088 | |
| 271 | Phosphorylation | EATSKDCSRLTNGPS CCCCCCHHHHCCCCC | 40.22 | 26074081 | |
| 274 | Phosphorylation | SKDCSRLTNGPSNGS CCCHHHHCCCCCCCC | 36.70 | 22199227 | |
| 278 | Phosphorylation | SRLTNGPSNGSSSRQ HHHCCCCCCCCCCCC | 56.04 | 26074081 | |
| 281 | Phosphorylation | TNGPSNGSSSRQRTS CCCCCCCCCCCCCCC | 29.41 | 22199227 | |
| 282 | Phosphorylation | NGPSNGSSSRQRTSG CCCCCCCCCCCCCCC | 30.82 | 26074081 | |
| 283 | Phosphorylation | GPSNGSSSRQRTSGS CCCCCCCCCCCCCCC | 33.84 | 26074081 | |
| 287 | Phosphorylation | GSSSRQRTSGSGFHR CCCCCCCCCCCCCCC | 29.15 | 20068231 | |
| 288 | Phosphorylation | SSSRQRTSGSGFHRE CCCCCCCCCCCCCCC | 32.90 | 25159151 | |
| 290 | Phosphorylation | SRQRTSGSGFHREGN CCCCCCCCCCCCCCC | 37.74 | 28985074 | |
| 298 | Phosphorylation | GFHREGNTTEDDFPS CCCCCCCCCCCCCCC | 42.28 | 22167270 | |
| 299 | Phosphorylation | FHREGNTTEDDFPSS CCCCCCCCCCCCCCC | 41.22 | 22167270 | |
| 305 | Phosphorylation | TTEDDFPSSPGNGNK CCCCCCCCCCCCCCC | 49.51 | 29255136 | |
| 306 | Phosphorylation | TEDDFPSSPGNGNKS CCCCCCCCCCCCCCC | 36.74 | 19664994 | |
| 313 | Phosphorylation | SPGNGNKSSNSSEER CCCCCCCCCCCCCCC | 38.46 | 23312004 | |
| 314 | Phosphorylation | PGNGNKSSNSSEERT CCCCCCCCCCCCCCC | 42.20 | 23312004 | |
| 316 | Phosphorylation | NGNKSSNSSEERTGR CCCCCCCCCCCCCCC | 40.86 | 23312004 | |
| 317 | Phosphorylation | GNKSSNSSEERTGRG CCCCCCCCCCCCCCC | 47.96 | 23312004 | |
| 326 | Phosphorylation | ERTGRGGSGYVNQLS CCCCCCCCCHHHHHH | 29.76 | 23663014 | |
| 328 | Phosphorylation | TGRGGSGYVNQLSAG CCCCCCCHHHHHHCC | 9.64 | 23663014 | |
| 333 | Phosphorylation | SGYVNQLSAGYESVD CCHHHHHHCCEECCC | 15.19 | 23663014 | |
| 336 | Phosphorylation | VNQLSAGYESVDSPT HHHHHCCEECCCCCC | 12.54 | 23663014 | |
| 338 | Phosphorylation | QLSAGYESVDSPTGS HHHCCEECCCCCCCC | 23.81 | 23663014 | |
| 341 | Phosphorylation | AGYESVDSPTGSENS CCEECCCCCCCCCCC | 23.39 | 23927012 | |
| 343 | Phosphorylation | YESVDSPTGSENSLT EECCCCCCCCCCCCC | 58.24 | 23927012 | |
| 345 | Phosphorylation | SVDSPTGSENSLTHQ CCCCCCCCCCCCCCC | 35.76 | 23927012 | |
| 348 | Phosphorylation | SPTGSENSLTHQSND CCCCCCCCCCCCCCC | 30.50 | 23927012 | |
| 350 | Phosphorylation | TGSENSLTHQSNDTD CCCCCCCCCCCCCCC | 20.07 | 23663014 | |
| 353 | Phosphorylation | ENSLTHQSNDTDSSH CCCCCCCCCCCCCCC | 29.12 | 23663014 | |
| 356 | Phosphorylation | LTHQSNDTDSSHDPQ CCCCCCCCCCCCCHH | 41.87 | 23663014 | |
| 358 | Phosphorylation | HQSNDTDSSHDPQEE CCCCCCCCCCCHHHH | 31.50 | 23663014 | |
| 359 | Phosphorylation | QSNDTDSSHDPQEEK CCCCCCCCCCHHHHH | 34.42 | 23663014 | |
| 387 | Phosphorylation | HVQNGLDSSVNVQGS HHCCCCCCCEECCCC | 41.03 | 20068231 | |
| 388 | Phosphorylation | VQNGLDSSVNVQGSV HCCCCCCCEECCCCC | 19.85 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FL2D_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FL2D_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FL2D_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| WT1_HUMAN | WT1 | physical | 11001926 | |
| MPPB_HUMAN | PMPCB | physical | 22939629 | |
| IKZF1_HUMAN | IKZF1 | physical | 25416956 | |
| VIR_HUMAN | KIAA1429 | physical | 26344197 | |
| ZC3HD_HUMAN | ZC3H13 | physical | 26344197 | |
| CAH4_HUMAN | CA4 | physical | 26071132 | |
| WT1_HUMAN | WT1 | physical | 26071132 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305 AND SER-306, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND MASSSPECTROMETRY. | |